{"id":16654,"date":"2022-02-10T08:50:54","date_gmt":"2022-02-10T13:50:54","guid":{"rendered":"https:\/\/www.emilysentourage.org\/?page_id=16654"},"modified":"2022-11-09T02:24:28","modified_gmt":"2022-11-09T07:24:28","slug":"emilys-entourage-announces-chandrabali-ghose-phd-as-first-ever-chief-scientific-officer","status":"publish","type":"post","link":"https:\/\/www.emilysentourage.org\/sv\/emilys-entourage-announces-chandrabali-ghose-phd-as-first-ever-chief-scientific-officer\/","title":{"rendered":"Emily's Entourage utser Chandrabali Ghose, PhD, till sin f\u00f6rsta Chief Scientific Officer n\u00e5gonsin"},"content":{"rendered":"

Dr. Chandra Ghose kommer att leda organisationens forsknings- och utvecklingsaktiviteter f\u00f6r att p\u00e5skynda utvecklingen av behandlingar f\u00f6r personer med s\u00e4llsynta former av cystisk fibros (CF)<\/i><\/strong><\/h3>\n

Lower Merion, PA - Emily's Entourage (EE), en innovativ 501(c)3-stiftelse som p\u00e5skyndar forskning f\u00f6r nya behandlingar och ett botemedel f\u00f6r nonsensmutationer av cystisk fibros (CF), meddelar att Dr. Chandra Ghose har utsetts till organisationens f\u00f6rsta Chief Scientific Officer n\u00e5gonsin. I denna nya roll kommer Dr. Ghose att definiera organisationens forskningsprioriteringar, bygga och utveckla allianser med intressenter, inklusive akademiska, industriella, ideella och statliga enheter, samt hantera den v\u00e4xande bidrags- och investeringsportf\u00f6ljen.<\/span><\/p>\n

\"Trots utvecklingen av banbrytande behandlingar f\u00f6r m\u00e5nga personer med CF, st\u00e5r 10% personer med CF utan behandlingar. Emily och hennes Entourages vision och obevekliga str\u00e4van efter att hitta snabba genombrott och ett botemedel f\u00f6r varje enskild person som lever med CF \u00e4r inspirerande\", s\u00e4ger Dr. Ghose. \"Jag ser fram emot att utnyttja min erfarenhet som forskare som blivit entrepren\u00f6r i min nya roll.\"<\/span><\/p>\n

Innan hon kom till Emily's Entourage var Dr. Ghose grundare och VD f\u00f6r Bioharmony Therapeutics, ett nystartat bioteknikf\u00f6retag som specialiserat sig p\u00e5 utveckling av nya antimikrobiella medel f\u00f6r att bek\u00e4mpa l\u00e4kemedelsresistenta bakterieinfektioner. Hon tillbringade \u00e5tta \u00e5r vid Aaron Diamond AIDS Research Center, ett dotterbolag till Rockefeller University, d\u00e4r hon fokuserade sin forskning p\u00e5 att utveckla livr\u00e4ddande vacciner i Dr. David Ho's laboratorium. Dessf\u00f6rinnan var Dr. Ghose postdoktor vid Harvard Medical School, Division of Infectious Diseases, Massachusetts General Hospital. Dr. Ghose har en doktorsexamen i mikrobiologi fr\u00e5n New York University School of Medicine och en kandidatexamen i biologi och teologi fr\u00e5n Saint Louis University.<\/span><\/p>\n

\"Att v\u00e4lkomna Dr. Ghose till v\u00e5rt team som v\u00e5r f\u00f6rsta Chief Scientific Officer n\u00e5gonsin \u00e4r ett historiskt \u00f6gonblick f\u00f6r Emily's Entourage och CF-communityn. Det \u00e5terspeglar v\u00e5rt orubbliga och f\u00f6rdjupade engagemang f\u00f6r att p\u00e5skynda livr\u00e4ddande forskning och terapeutisk utveckling f\u00f6r dem som befinner sig i den sista 10% av CF-communityn, med fokus p\u00e5 dem med CF-nonsensmutationer\", s\u00e4ger EE:s medgrundare Emily Kramer-Golinkoff. \"Med Dr. Ghoses unika kombination av djup vetenskaplig expertis, entrepren\u00f6rsbakgrund och passionerat ledarskap k\u00e4nner vi oss mer hoppfulla \u00e4n n\u00e5gonsin om framtiden f\u00f6r det terapeutiska CF-landskapet f\u00f6r de sista 10%.\"\u00a0\u00a0<\/span><\/p>\n

Ut\u00f6ver sin m\u00e5ngsidiga biomedicinska forskning har Dr. Ghose publicerat artiklar och bokkapitel med stort genomslag inom omr\u00e5det infektionssjukdomar och har f\u00e5tt m\u00e5nga utm\u00e4rkelser f\u00f6r sina vetenskapliga och entrepren\u00f6riella bidrag. Hon har arbetat som volont\u00e4r p\u00e5 C. Diff Foundation och p\u00e5 Pew Charitable Trusts program \"Supermoms against Superbugs\" f\u00f6r att \u00f6ka medvetenheten om antibiotikaresistens, en fr\u00e5ga som ligger henne varmt om hj\u00e4rtat. Hon \u00e4r ocks\u00e5 Fellow i den fj\u00e4rde klassen av Health Innovators Fellowship vid Aspen Institute och medlem av Aspen Global Leadership Network.<\/span><\/p>\n

###<\/p>\n

Om Emily's Entourage<\/b><\/p>\n

Emily's Entourage (EE) \u00e4r en innovativ 501(c)3-stiftelse som p\u00e5skyndar forskning f\u00f6r nya behandlingar och ett botemedel f\u00f6r nonsensmutationer av cystisk fibros (CF), en d\u00f6dlig genetisk sjukdom som fr\u00e4mst p\u00e5verkar lungorna och matsm\u00e4ltningssystemet. Sedan 2011 har EE delat ut miljontals dollar i forskningsanslag, startat ett CF-genterapibolag som f\u00f6rv\u00e4rvades av ett l\u00e4kemedelsbolag, utvecklat ett patientregister f\u00f6r CF-nonsensmutationer och ett matchningsprogram f\u00f6r kliniska pr\u00f6vningar f\u00f6r att p\u00e5skynda rekryteringen till kliniska pr\u00f6vningar samt lett v\u00e4rldsomsp\u00e4nnande insatser f\u00f6r att driva forskning och l\u00e4kemedelsutveckling med stor genomslagskraft. Organisationen har uppm\u00e4rksammats i nationella medier, bland annat The New York Times, STAT, CNN, People med flera.<\/span><\/p>\n

L\u00e4s mer om Emily's Entourage p\u00e5 <\/span>emilysentourage.org<\/span><\/a>.<\/span><\/p>","protected":false},"excerpt":{"rendered":"

Dr. Chandra Ghose kommer att leda organisationens forsknings- och utvecklingsaktiviteter f\u00f6r att p\u00e5skynda terapeutisk utveckling f\u00f6r individer med s\u00e4llsynta former av cystisk fibros (CF) Lower Merion, PA - Emily's Entourage (EE), en innovativ 501 (c) 3 stiftelse som p\u00e5skyndar forskning f\u00f6r nya behandlingar och ett botemedel f\u00f6r nonsensmutationer av cystisk fibros (CF), tillk\u00e4nnager utn\u00e4mningen av ... <\/p>\n

<\/div>\n

L\u00e4s mer om<\/a><\/p>","protected":false},"author":1281,"featured_media":16426,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_seopress_titles_title":"Emily\u2019s Entourage Announces Chandrabali Ghose, PhD, as First-Ever Chief Scientific Officer","_seopress_titles_desc":"Emily\u2019s Entourage (EE), an innovative 501(c)3 foundation that accelerates research for new treatments and a cure for nonsense mutations of cystic fibrosis (CF), announces the appointment of Dr. Chandra Ghose as the organization\u2019s first-ever Chief Scientific Officer.","_seopress_robots_index":"","_seopress_robots_follow":"","_seopress_robots_imageindex":"","_seopress_robots_snippet":"","_seopress_robots_primary_cat":"","_seopress_robots_breadcrumbs":"","_seopress_robots_freeze_modified_date":"","_seopress_robots_custom_modified_date":"","_seopress_robots_canonical":"","_seopress_social_fb_title":"","_seopress_social_fb_desc":"","_seopress_social_fb_img":"","_seopress_social_fb_img_attachment_id":0,"_seopress_social_fb_img_width":0,"_seopress_social_fb_img_height":0,"_seopress_social_twitter_title":"","_seopress_social_twitter_desc":"","_seopress_social_twitter_img":"","_seopress_social_twitter_img_attachment_id":0,"_seopress_social_twitter_img_width":0,"_seopress_social_twitter_img_height":0,"_seopress_redirections_value":"","_seopress_redirections_enabled":"","_seopress_redirections_enabled_regex":"","_seopress_redirections_logged_status":"both","_seopress_redirections_param":"","_seopress_redirections_type":301,"_seopress_analysis_target_kw":"","_seopress_news_disabled":"","_seopress_video_disabled":"","_seopress_video":[],"_seopress_pro_schemas_manual":[{"_seopress_pro_rich_snippets_type":"none"}],"_seopress_pro_rich_snippets_disable_all":"","_seopress_pro_rich_snippets_disable":[],"_seopress_pro_schemas":[],"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[178],"tags":[],"class_list":["post-16654","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-releases"],"acf":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Emilys-Entourage-Logo_Website-Featured-Image.png","post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/www.emilysentourage.org\/sv\/wp-json\/wp\/v2\/posts\/16654","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.emilysentourage.org\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.emilysentourage.org\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.emilysentourage.org\/sv\/wp-json\/wp\/v2\/users\/1281"}],"replies":[{"embeddable":true,"href":"https:\/\/www.emilysentourage.org\/sv\/wp-json\/wp\/v2\/comments?post=16654"}],"version-history":[{"count":2,"href":"https:\/\/www.emilysentourage.org\/sv\/wp-json\/wp\/v2\/posts\/16654\/revisions"}],"predecessor-version":[{"id":16662,"href":"https:\/\/www.emilysentourage.org\/sv\/wp-json\/wp\/v2\/posts\/16654\/revisions\/16662"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.emilysentourage.org\/sv\/wp-json\/wp\/v2\/media\/16426"}],"wp:attachment":[{"href":"https:\/\/www.emilysentourage.org\/sv\/wp-json\/wp\/v2\/media?parent=16654"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.emilysentourage.org\/sv\/wp-json\/wp\/v2\/categories?post=16654"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.emilysentourage.org\/sv\/wp-json\/wp\/v2\/tags?post=16654"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}